Article

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

2016-03-16

Abstract excerpt

<h4>SUMMARY</h4> <h4>Background:</h4> Advances in DNA sequencing have made gene testing fast and affordable, but adaptation of clinical services to capitalise on this for patient benefit has been slow. Ovarian cancer exemplifies limitations of current systems and potential benefits of increased gene testing. Approximately 15% of ovarian cancer patients have a germline mutation in BRCA1 or BRCA2 (collectively t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 579e0f11-8ec6-5640-9575-db125437ca0f
DOI: 10.1101/044024

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsDOI 10.1101/044024Read

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read

A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.Semantic proximity Read

Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.Semantic proximity Read

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialSemantic proximity Read

Routine germline genetic testing in 3552 unselected NHS breast cancer patients: Evidence informing testing criteria and implementation of a ‘BRCA-DIRECT’ mainstreaming pathwaySemantic proximity Read

Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testingSemantic proximity Read

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.Semantic proximity Read

Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model.Semantic proximity Read

A cost analysis of a cancer genetic service model in the UKSemantic proximity Read

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspectiveSemantic proximity Read

Cascade testing in an ovarian cancer traceback genetic testing program: The GRACE study experience.Semantic proximity Read

Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their managementSemantic proximity Read